Workflow
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet

Amneal Pharmaceuticals (AMRX) closed the last trading session at 8.17,gaining18.17, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of 11.75 indicates a 43.8% upside potential.The average comprises four short-term price targets ranging from a low of 11.00toahighof11.00 to a high of 12.00, with a standard deviation of $0.5. While the lowest estimate indicates an increase of 34.6% from the current ...